Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts.
about
Transjugular intrahepatic portosystemic shunts and portal hypertension-related complicationsTransjugular intrahepatic portosystemic shuntPassive expansion of sub-maximally dilated transjugular intrahepatic portosystemic shunts and assessment of clinical outcomes.A capillary blood ammonia bedside test following glutamine load to improve the diagnosis of hepatic encephalopathy in cirrhosis.Liver failure after an uncovered TIPS procedure associated with hepatic infarctionAcute esophageal variceal bleeding: Current strategies and new perspectivesTIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: an updated meta-analysisTransjugular intrahepatic portosystemic shunt for severe jaundice in patients with acute Budd-Chiari syndrome.Using transjugular intrahepatic portosystemic shunts for complications of cirrhosis.Hyponatremia: A Risk Factor for Early Overt Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt CreationTransjugular intrahepatic portosystemic shunt for the treatment of medically refractory ascitesThe brain following transjugular intrahepatic portosystemic shunt: the perspective from neuroimaging.Effect of renal function impairment on the mortality of cirrhotic patients with hepatic encephalopathy: a population-based 3-year follow-up study.Transjugular intrahepatic portosystemic shunt vs endoscopic therapy in preventing variceal rebleeding.Efficacy of covered and bare stent in TIPS for cirrhotic portal hypertension: A single-center randomized trial.The Evolution of Transjugular Intrahepatic Portosystemic Shunt: Tips.Clinical effects and complications of TIPS for portal hypertension due to cirrhosis: a single centerEmerging drugs for hepatic encephalopathy.Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt.Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: a systematic review.Satavaptan treatment for ascites in patients with cirrhosis: a meta-analysis of effect on hepatic encephalopathy development.Cirrhotic ascites review: Pathophysiology, diagnosis and management.Update on management of patients with overt hepatic encephalopathy.Long-term clinical outcome of patients with cirrhosis and refractory ascites treated with transjugular intrahepatic portosystemic shunt insertion.Clearing the Confusion over Hepatic Encephalopathy After TIPS Creation: Incidence, Prognostic Factors, and Clinical Outcomes.Endovascular Management of Refractory Hepatic Encephalopathy Complication of Transjugular Intrahepatic Portosystemic Shunt (TIPS): Comprehensive Review and Clinical Practice Algorithm.Keeping high model for end-stage liver disease score liver transplantation candidates alive.The Changing Role of Sodium Management in Cirrhosis.Prevention and treatment of variceal haemorrhage in 2017.An Algorithm for Management After Transjugular Intrahepatic Portosystemic Shunt Placement According to Clinical Manifestations.Pathological Predictors of Shunt Stenosis and Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt.Cognitive reserve is a resilience factor for cognitive dysfunction in hepatic encephalopathy.Procedural and shunt-related complications and mortality of the transjugular intrahepatic portosystemic shunt (TIPSS).Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with recurrent variceal hemorrhage.Cognitive Impairment Predicts The Occurrence Of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt.Endovascular treatment of acute and chronic portal vein thrombosis in patients with cirrhotic and non-cirrhotic liver.Quality improvement guidelines for Transjugular Intrahepatic Portosystemic Shunt (TIPS).The transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension: current status.Hyponatraemia and cirrhosis.Ascites in patients with cirrhosis.
P2860
Q26860685-7BE0C475-3D4C-4E59-9214-671F2B993812Q26991832-51C668DB-CB99-4750-8120-FDCB57B06328Q33623245-742BA1C8-97DD-4AAE-8D89-856B151D3089Q34094175-53197A0A-7D51-4840-BC48-4DBA0A90C799Q34390250-55BE6F94-0658-47C8-B66F-A605B638E3B8Q34625821-49A5C001-E278-4B4B-B67C-E28F53000F3EQ35120398-7B2BD62A-6979-49F5-9552-F4E6EEC92A8CQ35128200-581CA785-B718-4F6E-B85A-CE2057256E64Q35435269-B039065B-BC2A-4B3A-98D9-F90CADEE6D42Q35667270-661B6FE5-FDC2-45A2-B3D2-FF7C0299F1DDQ35720298-8CE568E7-C19A-4998-B0CE-D16FE2EE0877Q35787166-3E6D3D2D-DC33-4E46-86D4-20E6657CE0D4Q36193403-2686EBBB-5AEF-4515-92FF-8DC949A253A5Q36529243-1D960D72-1CDE-4466-9072-C3D3426DB042Q36579559-4E72C55B-DAC3-45D9-9784-5DA2F7AF306EQ36961977-6681AF40-A052-4074-9C71-04E9D6039BC8Q37358670-778AE37A-F4A1-4EB8-870A-36A74819244CQ37529838-9B368DFF-3FED-49D5-8642-3D0F3471762AQ37578597-8348E195-BEBF-4CBF-9904-3631AC168C1FQ37830756-C7C1FB97-0312-4417-9857-ABAB77477C2EQ38086800-CD53E64A-AF10-447D-AA75-A42135565FF6Q38110291-DCF7D02F-C293-4A0F-8781-A98704B0DF64Q38129187-8E5A78E9-A3BD-409B-A541-BD83E00FDE84Q38244333-930FD210-D37C-4CC0-B474-C97D35345E5FQ38260345-7ABADCBE-A3CB-4CF1-861F-ED89C3DF3F79Q38569150-D6DBCF81-617B-4F63-9E06-A258C0E10C5FQ38579840-4E5F41B9-AB5D-4E71-BBCB-D5290A35EE28Q38796241-96A652C9-6F85-4C84-B024-2DD7D8447812Q39067320-76EB0FDD-54A7-4F5E-81C7-3AD9A83A3E60Q39069550-DBA59132-4D9F-4FAF-8CA4-09FC7917CDA4Q39100042-75D7640C-07CF-4581-B891-369F8649D68BQ39307817-A957B1E1-DC94-454A-BB99-BC42687C8D84Q39350041-373B2C9D-4B95-4919-BA07-315EAE709C8DQ39826745-3BFD390A-0E2C-4379-BA22-8604EDE3A07AQ39960434-63566417-BB9A-4F3A-A54E-589959C950A4Q40646577-3080A408-5820-4870-ACF2-5446E744D5D8Q41471397-930C5B2F-4585-42A3-A93E-A39773A501A4Q41842278-9B69619B-9FAA-48CE-946E-3F6D566C47DBQ41946824-6C40B707-EA8D-4D7D-B031-BBE05789AA2EQ42139571-C577C8C9-CEF6-44BB-832F-A7BE9D5E42C2
P2860
Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Incidence, natural history, an ...... ethylene-covered stent grafts.
@en
Incidence, natural history, an ...... ethylene-covered stent grafts.
@nl
type
label
Incidence, natural history, an ...... ethylene-covered stent grafts.
@en
Incidence, natural history, an ...... ethylene-covered stent grafts.
@nl
prefLabel
Incidence, natural history, an ...... ethylene-covered stent grafts.
@en
Incidence, natural history, an ...... ethylene-covered stent grafts.
@nl
P2093
P2860
P50
P1476
Incidence, natural history, an ...... ethylene-covered stent grafts.
@en
P2093
Federica Cerini
Filippo Maria Salvatori
Stefania Angeloni
P2860
P304
P356
10.1111/J.1572-0241.2008.02102.X
P407
P577
2008-09-04T00:00:00Z